The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of rovalpituzumab tesirine in patients With DLL3-expressing, ≥ 3rd line small cell lung cancer: Results from the phase 2 TRINITY study.
 
David Paul Carbone
Consulting or Advisory Role - Abbvie; Adaptimmune; Agenus; Amgen; ARIAD; AstraZeneca; Biocept; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Foundation Medicine; Genentech/Roche; Gritstone Bio; Guardant Health; Inovio Pharmaceuticals; Merck; MSD; Novartis; Palobiofarma; Pfizer; Prime Oncology
Research Funding - Bristol-Myers Squibb
 
Daniel Morgensztern
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Heat Biologics
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Sylvestre Le Moulec
No Relationships to Disclose
 
Rafael Santana-Davila
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim
Research Funding - Abbvie (Inst); Bayer (Inst); BeyondSpring Pharmaceuticals (Inst); Genentech (Inst); Lilly (Inst)
 
Neal Ready
Consulting or Advisory Role - Ariad
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Loxo (Inst); Mirati Therapeutics (Inst); Tesaro (Inst)
 
Christine L. Hann
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Genentech/Roche
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); EnGeneIC (Inst); GlaxoSmithKline (Inst); GlaxoSmithKline (Inst); Merrimack (Inst)
 
Bonnie S. Glisson
Research Funding - Abbvie/Stemcentrx (Inst); Bristol-Myers Squibb (Inst); ISA Pharmaceuticals (Inst); Medimmune (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Abbvie/Stemcentrx; ISA Pharmaceuticals
 
Afshin Dowlati
Consulting or Advisory Role - ARIAD
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst); Loxo (Inst); Mirati Therapeutics (Inst); Tesaro (Inst)
 
Charles M. Rudin
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Harpoon Therapeutics; Seagen
 
Satwant Lally
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
Sreeni Yalamanchili
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
Juergen Wolf
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Chugai Pharma; Ignyta; Lilly; MSD; Novartis; Pfizer
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Novartis (Inst)
 
Ramaswamy Govindan
Honoraria - Boehringer Ingelheim; Genentech/Abbvie
Consulting or Advisory Role - Abbvie; AstraZeneca/MedImmune; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; EMD Serono; Genentech/Roche; GlaxoSmithKline; Inivata; Merck Serono; Novartis; Pfizer
Research Funding - Abbvie (Inst); Bayer (Inst); GlaxoSmithKline (Inst); MethylGene (Inst)
Travel, Accommodations, Expenses - Amgen; Boehringer Ingelheim; Celgene; Genentech; GlaxoSmithKline; Merck
 
Benjamin Besse
Research Funding - Abbvie (Inst)